Literature DB >> 22953182

Diabetes management and hypoglycemia in safety sensitive jobs.

See-Muah Lee1, David Koh, Winnie Kl Chui, Chee-Fang Sum.   

Abstract

The majority of people diagnosed with diabetes mellitus are in the working age group in developing countries. The interrelationship of diabetes and work, that is, diabetes affecting work and work affecting diabetes, becomes an important issue for these people. Therapeutic options for the diabetic worker have been developed, and currently include various insulins, insulin sensitizers and secretagogues, incretin mimetics and enhancers, and alpha glucosidase inhibitors. Hypoglycemia and hypoglycaemic unawareness are important and unwanted treatment side effects. The risk they pose with respect to cognitive impairment can have safety implications. The understanding of the therapeutic options in the management of diabetic workers, blood glucose awareness training, and self-monitoring blood glucose will help to mitigate this risk. Employment decisions must also take into account the extent to which the jobs performed by the worker are safety sensitive. A risk assessment matrix, based on the extent to which a job is considered safety sensitive and based on the severity of the hypoglycaemia, may assist in determining one's fitness to work. Support at the workplace, such as a provision of healthy food options and arrangements for affected workers will be helpful for such workers. Arrangements include permission to carry and consume emergency sugar, flexible meal times, self-monitoring blood glucose when required, storage/disposal facilities for medicine such as insulin and needles, time off for medical appointments, and structured self-help programs.

Entities:  

Keywords:  Blood glucose awareness training (BGAT); Fitness to work; Hypoglycemic unawareness; Safety sensitive; Self-monitoring blood glucose

Year:  2011        PMID: 22953182      PMCID: PMC3431894          DOI: 10.5491/SHAW.2011.2.1.9

Source DB:  PubMed          Journal:  Saf Health Work        ISSN: 2093-7911


  19 in total

1.  NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.

Authors:  N MCINTYRE; C D HOLDSWORTH; D S TURNER
Journal:  Lancet       Date:  1964-07-04       Impact factor: 79.321

Review 2.  Strategies for insulin therapy in type 2 diabetes.

Authors:  Steven V Edelman; Candis M Morello
Journal:  South Med J       Date:  2005-03       Impact factor: 0.954

Review 3.  Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

Authors: 
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

4.  Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.

Authors:  Alex D Wright; Carole A Cull; Kenneth M Macleod; Rury R Holman
Journal:  J Diabetes Complications       Date:  2006 Nov-Dec       Impact factor: 2.852

5.  Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes.

Authors:  J Geddes; J E Schopman; N N Zammitt; B M Frier
Journal:  Diabet Med       Date:  2008-04       Impact factor: 4.359

6.  Simple versus complex performance impairments at three blood glucose levels.

Authors:  C S Holmes; K M Koepke; R G Thompson
Journal:  Psychoneuroendocrinology       Date:  1986       Impact factor: 4.905

7.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

8.  Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes: effect of impaired awareness of hypoglycemia.

Authors:  Nicola N Zammitt; Roderick E Warren; Ian J Deary; Brian M Frier
Journal:  Diabetes       Date:  2007-11-26       Impact factor: 9.461

9.  Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE.

Authors:  A Dornhorst; H-J Lüddeke; C Koenen; M Meriläinen; A King; A Robinson; S Sreenan
Journal:  Diabetes Obes Metab       Date:  2007-11-22       Impact factor: 6.577

10.  Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

Authors:  Francesca Porcellati; Paolo Rossetti; Natalia Ricci Busciantella; Stefania Marzotti; Paola Lucidi; Steven Luzio; David R Owens; Geremia B Bolli; Carmine G Fanelli
Journal:  Diabetes Care       Date:  2007-07-10       Impact factor: 19.112

View more
  4 in total

1.  Development of a Diabetes Mellitus Knowledge Resource for Clinical Decision Support Assisting Primary Care Physicians With Work-Related Issues.

Authors:  Anna Allen; Laura Welch; Katherine Kirkland; Douglas Trout; Sherry Baron
Journal:  J Occup Environ Med       Date:  2017-11       Impact factor: 2.162

2.  Loss of consciousness in a helicopter pilot as plausible first sign of insulinoma: a case report.

Authors:  Simone Pratò; Vittoria Didonna; Francesca Garletti; Giovanni Marfia; Adriano Barbaresi; Fabrizio Palumbo; Emanuele Garzia; Giuseppe Ciniglio Appiani; Luciano Riboldi; Luisella Vigna
Journal:  Med Lav       Date:  2022-02-22       Impact factor: 1.275

3.  Diabetes management and hyperglycemia in safety sensitive jobs.

Authors:  See-Muah Lee; David Koh; Sharon Nne Fun; Chee-Fang Sum
Journal:  Saf Health Work       Date:  2011-12-05

Review 4.  Hypoglycemia: The neglected complication.

Authors:  Sanjay Kalra; Jagat Jyoti Mukherjee; Subramanium Venkataraman; Ganapathi Bantwal; Shehla Shaikh; Banshi Saboo; Ashok Kumar Das; Ambady Ramachandran
Journal:  Indian J Endocrinol Metab       Date:  2013-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.